ACTIVE

Lobelia Pharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

274,2 k €

+9.5% YoY

Gross margin

200,9 k €

+153.8% YoY

Equity

1,5 M €

+22.1% YoY

What does Lobelia Pharma do?

Lobelia Pharma is a Private limited company incorporated in 2000. Its main activity is: Management consultancy activities. Its registered office is in Brugge.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0471.133.849

Incorporation

23/02/2000

Legal form

Private limited company

Registered office

Koning Leopold III-laan 128
8200 Brugge · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2007
Income statement
Gross margin	200,9 k €	+154%	79,1 k €	+7.4%	73,7 k €	+29.3%	57 k €	-26.4%	77,4 k €	+19.6%	64,7 k €	+13.0%	57,3 k €	+1583%	-3,9 k €	-66.5%	-2,3 k €	-129%	7,9 k €	+5.4%	7,5 k €	+140%	3,1 k €	-84.9%	20,8 k €	+5933%	-355,9 €	-119%	1,8 k €	+382%	-652,3 €	-102%	40,5 k €	-66.4%	120,7 k €	+27.5%	94,6 k €	-32.5%	140,1 k €
EBITDA	198,6 k €	+155%	77,8 k €	+9.3%	71,2 k €	+30.6%	54,5 k €	-27.6%	75,4 k €	+20.3%	62,6 k €	+15.1%	54,4 k €	+1019%	-5,9 k €	-41.3%	-4,2 k €	-171%	5,9 k €	+20.9%	4,9 k €	+983%	451 €	-97.4%	17,5 k €	+634%	-3,3 k €	-1298%	-235,2 €	+89.6%	-2,3 k €	-106%	38,4 k €	-67.5%	118 k €	+28.1%	92,1 k €	-18.4%	112,9 k €
Operating result	103,9 k €	+33.5%	77,8 k €	+9.3%	71,2 k €	+30.6%	54,5 k €	-27.6%	75,4 k €	+20.3%	62,6 k €	+15.1%	54,4 k €	+1019%	-5,9 k €	+68.4%	-18,7 k €	+10.7%	-21 k €	+14.7%	-24,6 k €	-8.2%	-22,7 k €	-236%	-6,8 k €	+60.7%	-17,2 k €	-719%	-2,1 k €	+27.2%	-2,9 k €	-108%	37,7 k €	-65.5%	109,2 k €	+31.5%	83,1 k €	-16.8%	99,8 k €
Net result	274,2 k €	+9.5%	250,3 k €	+683%	32 k €	-65.3%	92,2 k €	-74.9%	366,9 k €	+775%	41,9 k €	-20.9%	53 k €	+1065%	4,6 k €	-93.2%	67 k €	+1805%	-3,9 k €	+60.3%	-9,9 k €	-245%	6,8 k €	-27.7%	9,5 k €	-45.7%	17,4 k €	+4.7%	16,6 k €	-10.4%	18,6 k €	-66.6%	55,7 k €	-40.2%	93,1 k €	+64.7%	56,5 k €	-20.9%	71,5 k €
Balance sheet
Equity	1,5 M €	+22.1%	1,2 M €	+25.3%	990,2 k €	+3.3%	958,2 k €	+10.6%	866 k €	+64.7%	525,8 k €	+8.7%	483,8 k €	+12.3%	430,8 k €	+1.1%	426,2 k €	+18.7%	359,2 k €	-1.1%	363,2 k €	-2.7%	373 k €	-39.3%	614,2 k €	+1.6%	604,8 k €	+3.0%	587,3 k €	-6.3%	626,5 k €	+3.1%	607,9 k €	+5.5%	576,3 k €	+19.3%	483,2 k €	+14.9%	420,4 k €
Total assets	3,5 M €	+49.3%	2,4 M €	+10.8%	2,1 M €	+4.3%	2,1 M €	-5.8%	2,2 M €	+5.5%	2,1 M €	-13.3%	2,4 M €	+437%	444,3 k €	+3.1%	431 k €	-0.9%	434,9 k €	-7.1%	468,1 k €	-6.6%	501,4 k €	-37.9%	807,6 k €	+0.1%	807 k €	+0.5%	802,8 k €	+17.1%	685,4 k €	+7.1%	640 k €	+9.0%	587,2 k €	+10.7%	530,2 k €	-21.0%	670,9 k €
Cash	25,5 k €	+2.8%	24,8 k €	+78.1%	13,9 k €	+191%	4,8 k €	-38.2%	7,7 k €	-38.5%	12,6 k €	-80.3%	63,7 k €	-29.8%	90,8 k €	-28.1%	126,3 k €	+1571%	7,6 k €	-61.2%	19,5 k €	+342%	4,4 k €	-89.8%	43 k €	+96.6%	21,8 k €	-76.9%	94,4 k €	+329%	22 k €	+75.6%	12,5 k €	+94.8%	6,4 k €	-66.6%	19,3 k €	-56.9%	44,6 k €
Debts	2 M €	+79.1%	1,1 M €	-1.7%	1,2 M €	+5.1%	1,1 M €	-16.6%	1,3 M €	-14.6%	1,5 M €	-18.7%	1,9 M €	+13895%	13,5 k €	+186%	4,7 k €	-93.8%	75,7 k €	-27.9%	104,9 k €	-18.2%	128,3 k €	-33.6%	193,3 k €	-4.4%	202,2 k €	-6.1%	215,4 k €	+266%	58,9 k €	+83.4%	32,1 k €	+193%	11 k €	-76.7%	47,1 k €	+481%	8,1 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Charlotte Delobel

Director · since 03 avril 2023

Active

Ended mandates

Charlotte Delobel

Director · since 01 janvier 2019

Ended

Charlotte Delobel

Manager · since 01 janvier 2019

Ended

Jean-Charles Delobel

Director · since 01 avril 2014 · until 04 juillet 2023

Ended

Jean-Charles Delobel

Director · since 01 avril 2014

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	16/07/2026	13/08/2025	08/08/2024	31/03/2023	11/08/2022	27/07/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	31/03/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	26/06/2026	16/07/2026	Dutch	PDF
Abridged model	31/12/2024	27/06/2025	13/08/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	08/08/2024	Dutch	PDF
Abridged model	31/12/2022	31/03/2023	31/03/2023	Dutch	PDF
Abridged model	31/12/2021	24/06/2022	11/08/2022	Dutch	PDF
Micro model	31/12/2020	25/06/2021	27/07/2021	Dutch	PDF
Micro model	31/12/2019	26/06/2020	21/08/2020	Dutch	PDF
Micro model	31/12/2018	28/06/2019	20/08/2019	Dutch	PDF
Micro model	31/12/2017	29/06/2018	29/08/2018	Dutch	PDF
Micro model	31/12/2016	30/06/2017	28/08/2017	Dutch	PDF
Abridged model	31/12/2015	24/06/2016	17/08/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	31/07/2015	Dutch	PDF
Abridged model	31/12/2013	27/06/2014	02/07/2014	Dutch	PDF
Abridged model	31/12/2012	28/06/2013	24/07/2013	Dutch	PDF
Abridged model	31/12/2011	29/06/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2010	24/06/2011	30/06/2011	Dutch	PDF
Abridged model	31/12/2009	25/06/2010	30/07/2010	Dutch	PDF
Abridged model	31/12/2008	26/06/2009	02/07/2009	Dutch	PDF
Abridged model	31/12/2007	27/06/2008	04/07/2008	Dutch	PDF
Abridged model	31/01/2007	16/04/2007	01/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

Charlotte Delobel

Director · since 03 avril 2023

Active

Ended mandates

Charlotte Delobel

Director · since 01 janvier 2019

Ended

Charlotte Delobel

Manager · since 01 janvier 2019

Ended

Jean-Charles Delobel

Director · since 01 avril 2014 · until 04 juillet 2023

Ended

Jean-Charles Delobel

Director · since 01 avril 2014

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office11/12/2025
MAATSCHAPPELIJKE ZETEL
PDF
Mandates24/08/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/04/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Restructuring18/11/2021
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Registered office27/08/2020
MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
PDF
Mandates21/02/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/04/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates02/01/2008
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025274,2 k €↑
2024
Annual accounts 2024250,3 k €↑
2023
Annual accounts 202332 k €↓
2022
Annual accounts 202292,2 k €↓
2021
Annual accounts 2021366,9 k €↑
2020
Annual accounts 202041,9 k €↓
2019
Annual accounts 201953 k €↑
2018
Annual accounts 20184,6 k €↓
2017
Annual accounts 201767 k €↑
2016
Annual accounts 2016-3,9 k €↑
2015
Annual accounts 2015-9,9 k €↓
2014
Annual accounts 20146,8 k €↓
2013
Annual accounts 20139,5 k €↓
2012
Annual accounts 201217,4 k €↑
2011
Annual accounts 201116,6 k €↓
2010
Annual accounts 201018,6 k €↓
2009
Annual accounts 200955,7 k €↓
2008
Annual accounts 200893,1 k €↑
2007
Annual accounts 200756,5 k €↓
2007
Annual accounts 200771,5 k €
23/02/2000
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Lobelia Pharma

Overview

What does Lobelia Pharma do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline